Controversies and Debates in ME/CFS Research

NoteChapter Abstract

Few illnesses have generated as much scientific and social controversy as ME/CFS. This chapter confronts the central disputes head-on: the contested nomenclature and definitions, the debate over diagnostic criteria, the PACE trial and its methodological aftermath, and the long-standing tension between psychogenic and biomedical explanatory models. It examines the exercise-therapy and deconditioning debates, the interpretive controversy surrounding the NIH effort-preference findings, and the relationship between post-COVID illness and ME/CFS. It also addresses the structural issues that shape the field — research funding disparities, blinding failures in trials, the weaponised use of catastrophizing, the historical pattern of psychosomatic attribution, and medical gaslighting — and how these affect scientific integrity and the trustworthiness of the evidence base.

NoteChapter Roadmap: How to Use This Chapter

For patients: read the PACE-controversy and psychogenic-debate sections to understand the history behind contested treatments and to arm yourself against psychosomatic dismissals; the medical-gaslighting section names the phenomenon you may have faced.

For caregivers: skim the deconditioning-hypothesis and exercise-debates sections to counter the common “just exercise more” advice, and the post-covid section for the long-COVID comparison.

For clinicians: read the diagnostic-controversies section to navigate the case-definition landscape, and the exercise-debates plus deconditioning-hypothesis sections to align practice with the post-NICE-2021 evidence.

For researchers: this chapter maps the field’s fault lines — start with the PACE-controversy and psychogenic-debate sections, then the structural issues (medical gaslighting, funding disparities, blinding failures) and scientific-integrity sections to close.

1 Contents